Scotland to Open First Drug Checking Service in Glasgow

Related Articles

Psiconáutica Editorial Team · October 6, 2026

In brief

  • The Scottish Government announced on September 23 that the country’s first local drug checking service will open in Glasgow in October 2026.
  • Samples will be sent to a new national laboratory at the University of Dundee; the service is limited to individuals over 18 who are dependent on illegal drugs.
  • The scheduled October 5 opening has been postponed due to “operational and technical complexities,” according to the STV network.

Scotland is set to launch its first local drug checking service. The Scottish Government announced the initiative on September 23, 2026, the same day official figures for 2025 drug-related deaths were released: 1,133, an 11% increase over the previous year. The service will allow individuals to submit a substance, receive a rapid analysis, and obtain harm reduction advice along with their results.

Location, eligibility, and funding

The service will be located in Glasgow at the same site as The Thistle, the city’s supervised consumption room. Samples will be sent to a newly created national analysis and research laboratory housed at the Leverhulme Research Centre for Forensic Science at the University of Dundee. The government claims to have invested over £1.7 million ($2.2 million) in this pilot program and is planning three additional services: Aberdeen and Dundee have already received licenses from the British Home Office, and Edinburgh is preparing its application.

Leer más  Psilocybin and Alzheimer’s: A Case Study of Transient Improvements

Drugs Minister Maree Todd stated that the service will help people “make safer decisions,” which she considers particularly important due to the prevalence of nitazenes—synthetic opioids that significantly increase the risk of overdose.

The context: 1,133 deaths in 2025

According to data from National Records of Scotland, the rate of 21.4 deaths per 100,000 inhabitants is four times higher than in the year 2000, when current records began, and 2025 marks the sixth-worst year on record. Nitazenes were implicated in 247 deaths, 215 of which involved etonitazene. Opiates or opioids, cocaine, and benzodiazepines remain the most frequently cited substances, and 78% of fatalities involved a combination of drugs. Cases involving cocaine rose by 23% compared to 2024.

Data from The Thistle adds nuance: cocaine dropped from 81% of substances injected in January 2026 to 54% in July, while heroin use rose from 10% to 28%. Catriona Matheson, a professor at the University of Stirling, attributed the rise in deaths primarily to changes in the illicit market, with nitazenes and sedatives like xylazine and medetomidine contaminating opioids and benzodiazepines. She added that progress in creating these services has been “too slow.”

Leer más  Eli Lilly buys 5-MeO-DMT nasal spray for up to $3.8 billion

What it entails

The British license sets strict parameters: only those over 18 who are dependent on one or more illegal drugs may use the service. By design, this excludes occasional users, a demographic typically served by drug checking services at festivals in other countries. There is also no data yet on real-world operation: on October 2, STV reported that the opening scheduled for Monday, October 5, at Hunter Street was delayed due to “operational and technical complexities,” with no new date provided.

The figures framing the announcement reflect mortality, not the efficacy of the analysis; the pilot will need to demonstrate what changes in practice. Even so, the model aligns with findings from other centers: at the Sydney supervised consumption room, 16 out of 77 samples contained something unexpected. To review available tools, see our harm reduction and responsible use guide.

Source

Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.

Leer más  Two Psilocybin Doses for OCD: Johns Hopkins Trial Results

More on this topic

Comments

Advertisementspot_img

Popular stories